Literature DB >> 24179101

Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adults.

Poul Frølund Vestergaard1, Mette Hansen, Jan Frystyk, Ulrick Espelund, Jens S Christiansen, Jens Otto Lunde Jørgensen, Sanne Fisker.   

Abstract

OBJECTIVE: Senescent changes in body composition and muscle strength are accompanied by reduced production of GH and IGF1, but the causal relationship remains elusive. We speculate that serum bioactive IGF1, measured by the IGF1 kinase receptor activation assay, is closer related to human physiological ageing than total IGF1 measured by immunoassay.
DESIGN: We conducted a cross-sectional study in 150 adult males and females, between 20 and 70 years. After an overnight fasting, serum levels of bioactive IGF1, total IGF1 and IGF-binding protein 1 (IGFBP1) and IGFBP3 were assessed. Furthermore, body composition and muscle strength was measured.
RESULTS: Total IGF1 levels were higher in females (P=0.048). Bioactive IGF1 were identical in males and females (P=0.31), decreasing with age. Total IGF1 tended to decrease more with age compared with bioactive IGF1 (-1.48 vs -0.89 percent/year, P=0.052). Total body fat (TBF) was lower and BMI was higher in males (P<0.001 and P=0.005), and both increased with age. Knee extension and elbow flexion force were higher in males (P=0.001 and P=0.001), but decreased with age in both genders.  Total but not bioactive IGF1 was positively correlated to TBF, knee extension and muscle function in males. In multiple linear regression, only age predicted total IGF1, whereas age and IGFBP1 predicted bioactive IGF1.
CONCLUSIONS: Bioactive IGF1 tends to decrease to a lesser extent than total IGF1 with age and was not correlated with measures of body composition or muscle strength. Therefore, levels of circulating bioactive IGF1 does not appear to be a better biomarker of physiological ageing than total IGF1.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24179101     DOI: 10.1530/EJE-13-0661

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  13 in total

1.  The IGF-Axis and Diabetic Retinopathy Before and After Gastric Bypass Surgery.

Authors:  Troels Brynskov; Caroline Schmidt Laugesen; Andrea Karen Floyd; Jan Frystyk; Torben Lykke Sørensen
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

Review 2.  Translational implications of the interactions between hormones and age-related hearing loss.

Authors:  R D Frisina; P Bazard; M Bauer; J Pineros; X Zhu; B Ding
Journal:  Hear Res       Date:  2020-10-15       Impact factor: 3.208

3.  Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1.

Authors:  Meredith L Sosulski; Rafael Gongora; Svitlana Danchuk; Chunmin Dong; Fayong Luo; Cecilia G Sanchez
Journal:  Aging Cell       Date:  2015-06-09       Impact factor: 9.304

4.  Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.

Authors:  Felix P Bernhard; Sebastian Heinzel; Gerhard Binder; Karin Weber; Anja Apel; Benjamin Roeben; Christian Deuschle; Mirjam Maechtel; Tanja Heger; Susanne Nussbaum; Thomas Gasser; Walter Maetzler; Daniela Berg
Journal:  PLoS One       Date:  2016-03-11       Impact factor: 3.240

5.  miR-96, miR-145 and miR-9 expression increases, and IGF-1R and FOXO1 expression decreases in peripheral blood mononuclear cells of aging humans.

Authors:  Monika Budzinska; Magdalena Owczarz; Eliza Pawlik-Pachucka; Malgorzata Roszkowska-Gancarz; Przemyslaw Slusarczyk; Monika Puzianowska-Kuznicka
Journal:  BMC Geriatr       Date:  2016-11-30       Impact factor: 3.921

Review 6.  The Role of Insulin-Like Growth Factor 1 in the Progression of Age-Related Hearing Loss.

Authors:  Lourdes Rodríguez-de la Rosa; Luis Lassaletta; Miryam Calvino; Silvia Murillo-Cuesta; Isabel Varela-Nieto
Journal:  Front Aging Neurosci       Date:  2017-12-12       Impact factor: 5.750

7.  Dysregulated Cardiac IGF-1 Signaling and Antioxidant Response Are Associated with Radiation Sensitivity.

Authors:  Saeed Y Aghdam; Doreswamy Kenchegowda; Neel K Sharma; Gregory P Holmes-Hampton; Betre Legesse; Maria Moroni; Sanchita P Ghosh
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

8.  Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS).

Authors:  V Rochira; G Mossetto; N Jia; S Cannavo; P Beck-Peccoz; G Aimaretti; M R Ambrosio; C Di Somma; M Losa; D Ferone; C Lubrano; C Scaroni; A Giampietro; S M Corsello; M Poggi
Journal:  J Endocrinol Invest       Date:  2018-03-13       Impact factor: 4.256

9.  PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinoma.

Authors:  Jacob Thomsen; Rikke Hjortebjerg; Ulrick Espelund; Gitte Ørtoft; Poul Vestergaard; Nils E Magnusson; Cheryl A Conover; Trine Tramm; Henrik Hager; Claus Høgdall; Estrid Høgdall; Claus Oxvig; Jan Frystyk
Journal:  Oncotarget       Date:  2015-10-13

10.  Changes in insulin-like growth factor-I and -II associated with fat but not lean mass in early old age.

Authors:  David Bann; Jeff M P Holly; Hany Lashen; Rebecca Hardy; Judith Adams; Diana Kuh; Ken K Ong; Yoav Ben-Shlomo
Journal:  Obesity (Silver Spring)       Date:  2015-02-03       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.